ReviewCancer cell international2023

Enhancing HCC Treatment: innovatively combining HDAC2 inhibitor with PD-1/PD-L1 inhibition.

Rui Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.